 |
 |
|||||||
 |
 |
 |
 |
 |
 |
 |
 |
|
 |
|
|
|
|
|
|
|
|
| Overview Insight ALK Screen™ Insight ALK Resistance™ ALK Background & Significance |
Insight ALK Assays
Insight ALK Screen™ and Insight ALK Resistance™ provide detection of all fusion and point mutations across the spectrum of cancers where anaplastic lymphoma kinase (ALK) has known or suspected pathogenic roles. Insight also provides assays for monitoring ALK inhibitor therapy response with assays that detect and identify resistance mechanisms.
Co-Development & Research Services
Insight is actively engaged in discovery, clinical research and clinical assay development with diagnostic and biopharmaceutical partners. Our services include biomarker analysis in cell lines and tissue, gene expression profiling and companion diagnostic assay development.
